|Articles|June 29, 2023
DIA 2023: Keeping Patients Informed
Advertisement
In an interview at the 2023 DIA annual meeting with ACT editor, Andy Studna, Jean Sposaro, program lead, TransCelerate BioPharma, and director, global drug development operations industry collaborations, Bristol Myers Squibb discusses riaising awareness about clinical trials and increasing the public's trust in them.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
You've Been Spending Recruitment Money at the Wrong End of the Funnel
2
ACT Brief: NIH Funding Reshaping Development Strategy, Business Decision Setting Execution Course, and Complex Modality Platform Gaps
3
ACT Brief: Trial Execution Cost Burden and Protocol Variability, Real-World Oncology Data Curation Complexity, and Real-Time Analytics Datapoint Scale
4
$500,000 Lost a Day: The Economics of Clinical Trial Execution Is Pharma's Expensive Secret
5